02/18/2024

FDA Approves New Therapy for Melanoma

The cell therapy is the first to treat aggressive forms of it

The Food and Drug Administration (FDA_ has approved a novel type of cancer therapy to treat aggressive forms of melanoma using immune system cells from a patient's tumor.

The treatment, called Amtagvi, was developed by Iovance Biotherapeutics, a biotech company based in San Carlos, Calif.

It is intended for patients whose melanoma cannot be removed with surgery or has spread to other parts of the body.

Please select this link to read the complete article from NPR.